NextBillion - An Initiative of the William Davidson Institute at the University of Michigan

Friday, March 10, 2017

Common non-communicable diseases (NCDs), like diabetes and hypertension, are silent killers that plague a large percentage of the workforce and reduce productivity globally, posing a threat to the development of nearly any economy. NCDs account for over 38 million deaths every year, roughly 68% of the global deaths annually. In India, nearly one out of every ten persons aged 18 years and above has raised blood glucose, and 69.2 million people were diabetic in 2015.

To combat this growing epidemic, PSI/India and local partners work to prevent, detect and reduce the risk for type 2 diabetes and high blood pressure in Haryana State and Andhra Pradesh through Project Uday (meaning uprise). Eli Lilly & Company supports the consortium of local partners, which includes both the Public Health Foundation of India (PHFI) and Project Hope.

Eli Lilly & Company and The Confederation of Indian Industries hosted its annual NCD Summit where a diverse group of stakeholders from the public sector, civil society, state government, and medical community shared promising practices in diabetes care and management. PSI/India led the group in developing a white paper on promising practices in management of NCDs in India.